Medical Product Industry Ties to Patient Advocacy Organizations' Executive Leadership

Shamik Bhat; Joseph S Ross; Reshma Ramachandran

doi:10.1001/jamainternmed.2023.2842

Medical Product Industry Ties to Patient Advocacy Organizations' Executive Leadership

JAMA Intern Med. 2023 Oct 1;183(10):1164-1166. doi: 10.1001/jamainternmed.2023.2842.

Authors

Shamik Bhat¹, Joseph S Ross^{2

3

4

5}, Reshma Ramachandran^{2

3}

Affiliations

¹ Yale School of Medicine, New Haven, Connecticut.
² Section of General Internal Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
³ Yale Collaboration for Regulatory Rigor, Integrity and Transparency, Yale School of Medicine, New Haven, Connecticut.
⁴ Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut.
⁵ Center for Outcomes Research and Evaluation, Yale-New Haven Health System, New Haven, Connecticut.

PMID: 37603342
PMCID: PMC10442781 (available on 2024-08-21)
DOI: 10.1001/jamainternmed.2023.2842

No abstract available

Plain language summary

This cross-sectional study examines the ties between pharmaceutical and medical device industries and the executive leadership of the 50 highest-revenue US-based patient advocacy organizations.

Medical Product Industry Ties to Patient Advocacy Organizations' Executive Leadership

Authors

Affiliations

Plain language summary

Publication types

MeSH terms

Grants and funding